EYPT

Q: What is the price of EyePoint Pharmaceuticals (EYPT) today?

The price of EyePoint Pharmaceuticals (EYPT) today is R$ 65,26, with a variation of 29.46% compared to the last year. The price of EyePoint Pharmaceuticals (EYPT) started the year trading around R$ 40,38 and today it is at R$ 65,26. Follow the real-time price chart, the historical price of EyePoint Pharmaceuticals (EYPT), and stock data from Ibovespa and international markets.

Q: When does EyePoint Pharmaceuticals (EYPT) pay dividends?

EyePoint Pharmaceuticals (EYPT) did not distribute dividends in the last year.

Q: EyePoint Pharmaceuticals (EYPT) is it worth it?

Currently, EyePoint Pharmaceuticals (EYPT) is priced at R$ 65,26, with a P/E of -4,72%, representing a deviation of -5,85% from its historical average P/E. In the last year, the stock showed a variation of 29.46% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 29,46%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy shares of EyePoint Pharmaceuticals (EYPT)?

Investing in shares of EyePoint Pharmaceuticals (EYPT) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 shares of EyePoint Pharmaceuticals (EYPT) yield today?

The yield of EyePoint Pharmaceuticals (EYPT) was 14,89% in the last month, 29,46% in the last year and 114,50% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 shares of EyePoint Pharmaceuticals (EYPT) today, the total investment would be based on the current price of R$ 65,26.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 8.448,15In 5 years: R$ 13.997,58In 10 years: 2.095,40It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

EyePoint Pharmaceuticals Inc.

Price

US$ 12,04

variation (12m)

29,46%

p/l

-4,72

p/vp

3,37

DIVIDEND YIELD

0,00%

quote EYPT

BVMF

EYPT

If you had invested

year ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of EYPT

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

14,89%

3 months

71,24%

1 year

29,46%

2 years

3,35%

5 years

114,50%

10 years

-67,89%

real profitability

profitability minus inflation.

1 month

14,89%

3 months

70,39%

1 year

23,01%

2 years

-5,79%

5 years

56,74%

10 years

-80,96%

Indicators EYPT

check out the fundamentals of EyePoint Pharmaceuticals shares

P/L

-4,72

Sector: -1,52 Industry: -3,80

P/SALES (PSR)

15,96

Sector: 1,99 Industry: 2,90

P/VP

3,37

Sector: 2,16 Industry: 1,76

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

-58,24%

Sector: -26,53% Industry: -56,94%

ROE

-71,29%

Sector: -31,21% Industry: -45,34%

ROIC

-618,87%

Sector: -404,40% Industry: -420,46%

Net Margin

-100,00%

Sector: -26,56% Industry: -32,35%

GROSS MARGIN

95,16%

Sector: 44,49% Industry: 44,86%

OPERATING MARGIN

-100,00%

Sector: -23,10% Industry: -30,21%

P/EBITDA

-4,59

Sector: 0,07 Industry: -2,60

P/EBIT

-4,56

Sector: -1,37 Industry: -3,22

P/ASSETS

2,75

Sector: 1,23 Industry: 1,32

VPA

3,51

Sector: 3,66 Industry: 1,68

LPA

-2,51

Sector: -0,80 Industry: -1,22

EQUITY / ASSETS

0,82

Sector: 0,45 Industry: 0,48

CAGR REVENUES 5 YEARS

8,55%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

31,04%

Sector: - Industry: -

EYPT indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	Net Margin
LLY	45,25	34,03	75,21%	0,81%	US$ 624,41 B	25,91%
ISRG	65,56	9,52	14,52%	0,00%	US$ 170,94 B	28,51%
TMO	28,71	3,73	13,01%	0,33%	US$ 189,00 B	15,24%
MDT	25,50	0,00	0,00%	3,03%	US$ 118,85 B	13,63%
SNY	11,17	1,55	13,90%	4,31%	US$ 125,86 B	14,83%
CVS	19,92	1,16	5,84%	3,73%	US$ 90,27 B	1,17%
GSK	17,94	4,15	23,12%	4,04%	US$ 80,77 B	10,87%
ABT	15,66	4,31	27,50%	1,81%	US$ 218,97 B	32,43%
NVS	18,12	5,88	32,47%	3,05%	US$ 247,36 B	24,74%
TMDX	56,86	12,81	22,53%	0,00%	US$ 4,07 B	13,49%
HCA	16,35	-78,84	-482,31%	0,68%	US$ 97,60 B	8,21%
BSX	62,73	6,94	11,06%	0,00%	US$ 157,13 B	13,54%
INMD	5,22	1,48	28,44%	0,00%	US$ 933,03 M	44,50%
DHR	44,49	2,90	6,52%	0,56%	US$ 151,86 B	14,21%
IDXX	52,40	35,40	67,57%	0,00%	US$ 51,64 B	24,41%
FMS	20,59	0,91	4,42%	3,07%	US$ 15,03 B	3,41%
HUM	23,00	1,98	8,61%	1,18%	US$ 36,24 B	1,28%
PHG	127,59	2,23	1,75%	3,13%	US$ 26,81 B	1,07%
DXCM	56,42	12,53	22,21%	0,00%	US$ 32,25 B	13,29%

comparison of EYPT with indexes

If you had invested (change) 2 years a year ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history EYPT dividend history

Current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY EyePoint Pharmaceuticals

EyePoint Pharmaceuticals Inc.

Average user rating I10

4.0 (0 people)

Estados Unidos

17 years

Foundation: 2008

2008

Year of debut on the stock exchange - 17 years

84

Employees

The Company EyePoint Pharmaceuticals Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 828,10 Milhões, having a net worth of $ 246,01 Milhões.

With a total of 84 employees, the company is listed in the sector of Saúde and categorized in industry of Produtos Farmacêuticos.

In the last 12 months the Company had a revenue of $ 51,89 Milhões, which generated a loss in the amount of $ -175,39 Milhões.

As for its main indicators, the Company has a P/E ratio of -4,72, a P/B ratio of 3,37 and in the last 12 months the Company did not pay dividends.

The Company is traded through the ticker EYPT.

Market value

US$ 828,10 Milhões

Net worth

US$ 246,01 Milhões

US$ 246.010.000,00

Assets

US$ 301,15 Milhões

US$ 301.150.000,00

Total Number of Shares

70,00 Milhões

70.000.000

Average Daily Trading Volume

US$ 725,54 Thousand

US$ 725.540,34

Sector

Saúde

Industry

Produtos Farmacêuticos

EYPT

EYPT revenue and profits

EYPT results

DRAG THE FRAME TO SEE MORE DATA

EYPT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 71,55 30,23% (12 M)

P/L

19,92

3,73%

ROE

5,84%

P/VP

1,16

CI - Cigna

US$ 300,32 --13,19% (12 M)

P/L

16,13

1,91%

ROE

12,41%

P/VP

2,00

CNC - Centene

US$ 28,66 --63,26% (12 M)

P/L

7,07

0,00%

ROE

7,47%

P/VP

0,53

HUM - Humana

US$ 298,87 --14,32% (12 M)

P/L

23,00

1,18%

ROE

8,61%

P/VP

1,98

SNY - Sanofi

US$ 50,30 --6,73% (12 M)

P/L

11,17

4,31%

ROE

13,90%

P/VP

1,55

HCA - HCA Healthcare

US$ 401,96 4,05% (12 M)

P/L

16,35

0,68%

ROE

-482,31%

P/VP

-78,84

LLY - Eli Lilly

US$ 736,03 --22,19% (12 M)

P/L

45,25

0,81%

ROE

75,21%

P/VP

34,03

Common Questions

What is the price of EyePoint Pharmaceuticals (EYPT) today?

The price of EyePoint Pharmaceuticals (EYPT) today is R$ 65,26, with a variation of 29.46% compared to the last year. The price of EyePoint Pharmaceuticals (EYPT) started the year trading around R$ 40,38 and today it is at R$ 65,26. Follow the real-time price chart, the historical price of EyePoint Pharmaceuticals (EYPT), and stock data from Ibovespa and international markets.

When does EyePoint Pharmaceuticals (EYPT) pay dividends?

EyePoint Pharmaceuticals (EYPT) did not distribute dividends in the last year.

EyePoint Pharmaceuticals (EYPT) is it worth it?

Currently, EyePoint Pharmaceuticals (EYPT) is priced at R$ 65,26, with a P/E of -4,72%, representing a deviation of -5,85% from its historical average P/E. In the last year, the stock showed a variation of 29.46% in its price and distributed R$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 29,46%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy shares of EyePoint Pharmaceuticals (EYPT)?

Investing in shares of EyePoint Pharmaceuticals (EYPT) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

The BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 shares of EyePoint Pharmaceuticals (EYPT) yield today?

The yield of EyePoint Pharmaceuticals (EYPT) was 14,89% in the last month, 29,46% in the last year and 114,50% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 shares of EyePoint Pharmaceuticals (EYPT) today, the total investment would be based on the current price of R$ 65,26.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 8.448,15
In 5 years: R$ 13.997,58
In 10 years: 2.095,40

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

EYPT

EyePoint Pharmaceuticals Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of EYPT

check out the fundamentals of EyePoint Pharmaceuticals shares

P/L

P/SALES (PSR)

P/VP

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

Net Margin

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSETS

VPA

LPA

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years a year ago, today you would have

Current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY EyePoint Pharmaceuticals

EyePoint Pharmaceuticals Inc.

Estados Unidos

17 years

2008

84

PROFIT X PRICE EYPT

EYPT results

EYPT cash flow

evolution of assets - EYPT

EYPT balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80